Retinal gene therapy: The patient experience with Anna and Chelle May 27, 2026 Overview Mostrar la transcripción Overview On the Mayo Clinic Ophthalmology Podcast, a patient and her mother discuss Leber congenital amaurosis and the first U.S. Food and Drug Administration (FDA)-approved retinal gene therapy. VID-20609756 Profesionales médicos Retinal gene therapy: The patient experience with Anna and Chelle